1. Telaprevir: Clinical Pharmacokinetics, Pharmacodynamics, and Drug–Drug Interactions

   • Tony K. L. Kiang
   • Kyle J. Wilby
   • Mary H. H. Ensom

   Review Article 04 April 2013 Pages: 487 - 510

2. Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid

   • Antonello Di Paolo
   • Giovanni Gori
   • Mario Del Tacca

   Review Article 20 April 2013 Pages: 511 - 542

   

3. Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients

   • José Moltó
   • George Xinarianos
   • Marta Valle

   Original Research Article 15 March 2013 Pages: 543 - 553

   

4. A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults

   • Ibrahim Ince
   • Saskia N. de Wildt
   • Catherijne A. J. Knibbe

   Original Research Article 20 March 2013 Pages: 555 - 565

   

5. Prediction of Warfarin Maintenance Dose in Han Chinese Patients Using a Mechanistic Model Based on Genetic and Non-Genetic Factors

   • Yuan Lu
   • Jinbo Yang
   • Jin Yang

   Original Research Article 21 March 2013 Pages: 567 - 581

   

6. Prediction of drug-drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach

   • Marco Siccardi
   • Catia Marzolini
   • David Back

   Original Research Article 12 March 2013 Pages: 583 - 592

   

7. Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer

   • Masahide Fukudo
   • Yasuaki Ikemi
   • Toshiya Katsura

   Original Research Article 27 March 2013 Pages: 593 - 609

   

8. Erratum to: A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults

   • Ibrahim Ince
   • Saskia N. de Wildt
   • Catherijne A. J. Knibbe

   Erratum 17 May 2013 Pages: 611 - 611

9. Erratum to: Prediction of Drug–Drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach

   • Marco Siccardi
   • Catia Marzolini
   • David Back

   Erratum 30 April 2013 Pages: 613 - 614